GHK-Cu Peptide Draws Anti-Aging Buzz as 1973 Discovery Faces Thin Human Evidence
Updated
Updated · USA TODAY · Jun 13
GHK-Cu Peptide Draws Anti-Aging Buzz as 1973 Discovery Faces Thin Human Evidence
3 articles · Updated · USA TODAY · Jun 13
Summary
GHK-Cu — a copper peptide first identified in 1973 — is drawing fresh attention in skincare and longevity circles for claims it may support regeneration and reduce visible aging.
Topical use drives much of that interest: early studies suggest it may boost collagen and elastin, aid wound healing and possibly support hair growth with less irritation than retinoids.
Human evidence remains limited, especially beyond creams and serums, with broader claims around brain protection, nerve repair and lung healing still based largely on lab and animal research.
Safety questions center on oral and injectable products sold by wellness clinics and online, where FDA approval for anti-aging use is lacking and dosing, purity and long-term effects remain unclear.
Experts say topical GHK-Cu appears generally safe, but people who are pregnant, take medications or have copper-metabolism disorders such as Wilson’s disease should seek medical advice first.